Clinical Trials Directory

Trials / Completed

CompletedNCT01695655

Neovascularization Patterns in Corneal Graft Rejection

Status
Completed
Phase
Study type
Observational
Enrollment
44 (actual)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Corneal transplantation is the most commonly performed human tissue transplant worldwide. Over 40,000 corneal transplants occur in the US each year. . This study will determine specific corneal neovascularization (CN) patterns in human corneal allograft recipients to determine the characteristics that worsen the prognosis for graft survival. We will test the hypothesis that specific characteristics of CN are prognostic for corneal allograft rejection.

Detailed description

The investigators hope to enroll 240 subjects into the study. These patients will be enrolled prior to penetrating keratoplasty. They will be examined by the full protocol preoperatively, and postoperatively at 1 week, 1, 3, 6, 12, 18, and 24 months. During these visits slit lamp biomicroscopy will be used to study CN patterns, and take slit lamp photographs if there is any neovascularization detected, permitting us to develop algorithms of CN characteristics that are predictive for corneal allograft rejection and failure. The corneal tissue removed during these patients' surgeries will be evaluated histopathologically to identify inflammation and neovascularization to confirm and compare to what is seen clinically. There will be two short questionnaires conducted at each visit to assess stress levels.

Conditions

Timeline

Start date
2007-11-01
Primary completion
2015-12-01
Completion
2016-12-01
First posted
2012-09-28
Last updated
2017-03-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01695655. Inclusion in this directory is not an endorsement.